Amy Hont, MD
Washington, District of Columbia 20010
National Provider ID: 1013270685
Amy Hont, M.D., specializes in hematology and oncology at Children's National Hospital. Her research interests include immunotherapy and high-risk malignancies.
Catherine Bollard, M.D., M.B.Ch.B., selected to lead global Cancer Grand Challenges team
PRAME-specific T cell product may facilitate rapid treatment in cancer settings
It’s a three-peat! Children’s National again competes in STAT Madness
Children’s National competes in STAT Madness
STAT News: Here are the contenders for STAT Madness 2020
Houghtelin A, Bollard CM.Virus-specific T cells for the immunocompromised patient. Front Immunol. 2017;8:1272. doi:10.3389/fimmu.2017.01272.Houghtelin A, Kopp L, Pelayo-Katsanis L, et al. Extramedullary breast relapse of acute lymphoblastic leukemia controlled with a second allogeneic/autologous hematopoietic cell transplant. JAYAO. 2015;4:1.